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Abstract
The sparse nature of voluntarily reported drug safety
data benefits from a system that consolidates the
massive amount of data into a manageable format
for analysis. This has been done for Australian drug
safety data by the Australian Adverse Drug Reac-
tion Advisory Committee (ADRAC) for reactions us-
ing the systems organ class (SOC) ontology. There
has long been a need for a similar kind of grouping
to apply to drugs in this type of data. In ADRAC,
drugs are currently listed by trade-name, where only
some of these trade-names were assigned anatomical-
therapeutic-chemical classification (ATC) codes. We
assigned an ATC code for each ADRAC trade-name
and show that this ontology facilitates the detection
of drug class / reaction class associations at vari-
ous levels of specificity. This allows different views
of these associations (even very rare ones) and their
significance measured for the development of more
sensitive signal detection methods. We report that
this ATC classification enables both the grouping of
association rule approach that is useful for studying
rare associations, and the development of an adverse
reaction signal detection method.
1 Introduction
1.1 ADRAC Data
The Australian Adverse Drug Reaction Advisory
Committee (ADRAC) database has been developed
and maintained by the Therapeutic Goods Adminis-
tration (TGA) with the aim to detect signals from
adverse drug reactions (ADRs) as early as possible.
The ADRAC data contain 137,297 voluntarily re-
ported adverse drug reaction records involving 5057
different drugs, based on the ‘drug dictionary’ used
by ADRAC of 7416 available drug terms, and 868
different reactions, based on 1392 available reaction
terms. There are many fields in these data, such
as patient information (age, weight, and height), ex-
pert information (causality, outcome, and suspected
drug). There are two groups of ten fields, which are
allocated for drug terms and reaction terms. That
is, ADRAC data can only accommodate a maximum
of ten terms for drugs and reactions. A more de-
tailed account of the ADRAC database is given in
Mamedov et al. (2002). These data are derived
from voluntary reports, some of the problems and
advantages of such a reporting system are discussed
in Bates (2003), Heeley (2001), Pinkston and Swain
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(Pinkston, V. & Swain, E. J. 1998), Pirmohamed et
al. (Pirmohamed, M., Breckenridge, A. M., Kitter-
ingham, N. R. & Park,B. K. 1998), Troutman and
Doherty (Troutman, W. G. & Doherty, K. M. 2003),
van der Heijden et al. (van der Heijden, P. G. M., van
Puijenbroek, E. P., van Buuren, S. & van der Hofst-
ede, J. W. 2002), van Puijenbroek et al. (van Pui-
jenbroek, E. P., Diemount, W. L. & van Grootheest,
K. 2003).
1.2 Data Consolidation
The biggest challenge in summarizing safety data is
the need to consolidate the massive amount of data
into a manageable format. One way is to group the
safety data into K classes characterized by body sys-
tems and determined in conjunction with underlying
disease and treatments involved. Such pooling of data
through coding is especially helpful for rare events
Chuang-Stein (1998), Pinkston and Swain (1998).
This has been done for Australian drug safety data
by ADRAC for ADR terms using the body systems
organ class (SOC) grouping Saunders et al. Mamedov
et al. (2003), (Mamedov, M. & Saunders, G. 2004),
(Mamedov, M. & Saunders, G. 2002). For more de-
tails of SOC information in ADRAC see Saunders
(2004).
There has been a need for a similar kind of group-
ing to apply to drugs in these data, which are cur-
rently listed by trade-name Mamedov et al. (2003).
ADRAC had assigned some of these trade-names
anatomical-therapeutic-chemical classification (ATC)
codes, but in cases where the trade-name had more
than one ingredient, ATC codes were not assigned.
This paper reports application the classification de-
scribed in Saunders (2004), where each trade-name
code was assigned a corresponding ATC code.
1.3 Critical Terms
From the third quarter of 1998, a new field has been
added at the end of the WHO-ART file which indi-
cates Critical Terms. Critical terms are a subset of
adverse reaction terms referring to, or possibly be-
ing indicative of, serious disease states, which have
been regarded as particularly important to follow up.
WHO (2002), (World Health Organization 2002) This
component of expert knowledge has been incorpo-
rated into ADR signal detection. In this report we
weight critical reaction terms to highlight associations
which are likely to be of greater interest and particu-
larly for those that are rare.
2 Methods
2.1 Basis for drug classification
The ADRAC database uses the “drug trade-name”
field as the main field for drugs. This is not satis-
factory because the same drug can have more than
one trade-name, which dilutes the information for
that drug. Also it is difficult to group drugs using
this field. The classification system implemented was
the WHO Collaborating Centre for Drug Statistics
Methodology ATC codes in order to enable: (i) the
grouping of the same substance into one code, and (ii)
the grouping of related substances into more general
categories. To this purpose the ATC codes for drugs
have been purchased by us from Ms Kirsten Myhr,
RELIS Øst, Ulleva˝l University Hospital, 0407 OSLO
(http://www.whocc.no/).
2.2 ATC embedded code
The ATC encoding system implements an an embed-
ded encoding system, which employs a seven charac-
ter coding system. As an example, the first member
of the system will be used. For level 0, the charac-
ter is ‘A’, level 1 is ‘A01’, level 2 is ‘A01A’ , level
3 is ‘A01AA’ and level 4 is ‘A01AA01’. The em-
bedded coding can be utilized to simplify database
queries and algorithm coding. Employing this em-
bedded coding, which resides in the ATC code string,
can be now utilized to aggregate the data to the re-
quired level. There was a need, for the purposes of
associating ADRAC and ATC ingredient terms, to go
to level 4 (7 character). The ATC embedded code has
been utilized in our algorithms to traverse the ATC
hierarchy (tree). For details of the ATC hierarchy –
see Saunders (2004).
2.3 Classification of ADRAC data
All trade-name instances that had ingredients that
matched ones in the WHO ATC file were assigned
an ATC code. In cases where more than one code
was available for a particular ingredient, the most
generic one was chosen. The remaining trade-name
codes that had not been assigned an ATC code were
classified as described in Saunders (2004). For the
purposes of this present investigation, in cases where
the original drug code had more than one ingredient,
a unique code was assigned from ATC codes for com-
binations of ingredients. This was done in order to
preserve a one-to-one correspondence between origi-
nal drug codes and the ATC codes facilitating com-
parison of the two drug classification schema. This
resulted in 1806 ATC drug terms from the 5081 drug
trade-name terms.
2.4 Association Rules
The application of the ATC classification to the
ADRAC drugs effectively causes a dramatic reduc-
tion in number of drug terms. We had previously
tried to apply the methods for grouping association
rules Agrawal et al. (1993), which are described in
Ivkovic (2004), (Ivkovic, Sasa, Yearwood, John &
Stranieri, Andrew 2002), (Ivkovic, Sasa, Yearwood,
John & Stranieri, Andrew 2003), on ADRAC data
and found the number of drug terms were excessive.
Now we report that the association rule methods can
be usefully applied to the ADRAC data by exploit-
ing the hierarchical structures of the ATC and SOC
classifications to produce signals from associations be-
tween individual drug terms and reaction terms.
The convention used for the association rules (also
see Saunders et al. (2005)) is given by:
Figure 1: Reaction Classes differences and similari-
ties.
Definition 2.1 Association Rule Definition: If an-
tecedent ⇒ consequent.
Example from Figure 1 – highest point for rule 54:
R1 1500⇒ sex F 94%
if first reaction is 1500 (R1 1500) then records
containing sex female (sex F), confidence = 94%;
as conditional probability P:
P(sex F | R1 1500) = 0.94;
that is, 94% of records with first reaction (field)
being reaction 1500, were female.
2.5 Adverse Event Signalling
Since the ATC ontology made our association rule
method useful for investigating the ADRAC data, we
decided to develop an adverse event signalling method
which also exploited the ATC hierarchy. This method
begins at an ATC level specified by the user. It then
examines the children of this node and performs a
χ2 test. If any of these children have a significantly
higher number of reactions than expected (based on
the hypothesis that the children are the same) then
their children are tested. The search ends when there
are no more children (leaf node), that is the lowest
ATC level. Thus drugs are found that have signifi-
cantly greater numbers of reactions. As well as this
the report dates are grouped by month. For a given
drug or drug class another algorithm examines the
first three month period of reports for that drug. A
χ2 test is applied to the reaction frequencies for these
periods. If the χ2 test is not significant, the next
month is added and the test repeated. This is re-
peated until the last month. To add to this, reactions
carry an extra weighting if they belong to the critical
terms. In this way the seriousness of the reaction is
also evaluated for signal production.
3 Results
3.1 Investigation using Association Rules
Applying a drug classification to ADRAC drug terms
makes these data more amenable to analysis by meth-
ods that work best with a limited number of variables.
The ability to reduce the number of drug terms using
the ATC hierarchy facilitates the application of the
association rules data mining algorithms (1993). We
report here some preliminary results from grouping
association rules by content using ADRAC data.
To demonstrate some of the features of this
method we will show some association rules looking
at all 18 SOC reaction classes in reaction field 1. In
the legend Figure 1 “R1 SOC” antecedent repre-
sents the SOC of the first reaction. and characteristic
number 54 (sex F – consequent) represents sex fe-
male. It can be seen that: (i) Some reaction classes
contain a many female patients, (ii) others have a
very few, (iii) among all patient who reported foetal
disorders (reaction class 1500) 94% are female, (iv)
among all patient who reported endocrine disorders
(reaction class 900) more than 70% are males.
We can filter the graph output by showing very few
or many characteristics Figure 2 shows 99 characteris-
tics. Reactions are listed in the legend, where the top
entry, R1 100 means the first reaction field is SOC 100
(skin and appendage disorders – see Saunders (2004));
the consequent on the x-axis, for example, D1 A02
is the first drug field is drug class A02 (drugs for acid
related disorders – see Saunders (2004)), D2 0 means
no drug in second drug field, R3 1000 is third reac-
tion field is SOC 1000 (cardiovascular) and R3 0 no
reaction in that field, ageG 13to20 means age group
13–20 years, nreac 1 means number of reactions in
record equals 1, out 4 outcome code 4 (death as a re-
action – see Mamedov et al. (2002)), sex X – sex not
recorded, yrG 72to76 means year group 1972–1976.
In this graph we can select for age group differences
and similarities between reaction classes – see Figure
3.
In Figure 4 we show SOC 1600 (neonatal and in-
fancy disorders) and focus on a rare group of patients
with this disorder – 52 patients (only 0.04%). We
are interested to explore further the characteristics
of 13 to 20 years old patients with reaction 1600,
displayed in Figure 5, where 33% of patients with
neonatal and infancy disorder are teenagers – 17 pa-
tients. All teenage patients with this disorder are fe-
male (17/17 – 100%). Almost half recovered without
sequel (7/17 – 41%). 30% of these patients took drug
class N06 (psychoanaleptics). 30% of these patients
took drug class N02 (analgesics). 5% took NO2 as a
second drug.
Thus this method is able to ‘drill down’ with the
aid of the drug and reaction ontologies to reach fine
level associations. In the following section we apply
the drug and reaction ontologies, along with the criti-
cal term ontology to develop a more sensitive adverse
event signalling method than presently exists.
3.2 Ontologies to facilitate a more sensitive
adverse event signalling method’s devel-
opment
We are currently developing a more sensitive adverse
event signalling method, which is described in more
detail in Ivkovic et al. (2005). To illustrate our gen-
eral approach we select “N” (nervous system) for drug
class and cardiovascular system for SOC class. The
algorithm traverses down the ATC tree and finds the
drug Clozapine (N05AH02). It has found the drug
having the most cardiovascular reactions. The indi-
vidual reactions for this drug are illustrated in Figure
6, the blue gives the frequency of the reaction and the
red indicates the critical term status of the particular
reaction (10 if critical, 1 otherwise). The inclusion of
critical terms provides a means of assessing the se-
riousness of reactions, which in turn can be used to
give the level of warning indicated. We also group
report date as already described in Section 2.5 and
this is illustrated in Figure 7 showing the monthly re-
action counts for this drug. Here the signalling algo-
Figure 2: Graph Output Filtering - reaction charac-
teristics (R1 SOC code – SOC of first reaction field;
D1 ATC code – ATC class of first drug field).
Figure 3: Age group characteristics - closer view.
Figure 4: SOC 1600 Neonatal and infancy disorders.
Figure 5: Teenagers with Neonatal disorders.
Figure 6: Reactions for Clozapine (N05AH02) for re-
action class 1000 – Cardiovascular system.
rithm evaluated this drug and gives a report: “Null
hypothesis: There are no ADR signals in this time
span is REJECTED... ALERT...There is signal on
199908 (position 34).” This drug has produced a sig-
nal in August 1999. This algorithm has traversed all
the way down the ATC tree and produced a warning
with its time of occurrence.
4 Conclusions
The ATC ontology enables pooling of all data relat-
ing to a single ingredient, rather than having it split
between different trade-names. The fact that there
are several levels of granularity in this classification
allows analysis at different levels. We have demon-
strated that, using the ATC and SOC ontologies our
association rule methods can explore even very rare
associations in the ADRAC data. The tree structure
of the ATC ontology was exploited to develop a ad-
verse event signalling method that can ‘drill down’
the ATC tree to find individual drugs that have sig-
nificantly more reactions in a given SOC. Then, using
the critical term ontology, monthly reaction frequen-
cies are examined to produce warnings when reac-
Figure 7: Timing of reactions Clozapine (N05AH02)
for reaction class 1000 – Cardiovascular system.
tions rise to a significant level. Thus the application
of ontologies to drug safety data enables a significant
advance in adverse event signalling methodology.
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